The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
As of close of business last night, Universal Health Services, Inc’s stock clocked out at $218.69, down -2.93% from its previous closing price of $225.3. In other words, the price has decreased by -$2.93 from its previous closing price. On the day, 0.66 million shares were traded. UHS stock price reached its highest trading level at $227.16 during the session, while it also had its lowest trading level at $218.163.
Ratios:
To gain a deeper understanding of UHS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 123.26 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 14.37. For the most recent quarter (mrq), Quick Ratio is recorded 0.96 and its Current Ratio is at 1.03. In the meantime, Its Debt-to-Equity ratio is 0.71 whereas as Long-Term Debt/Eq ratio is at 0.60.
On July 16, 2025, BofA Securities Downgraded its rating to Underperform which previously was Neutral but kept the price unchanged to $185.
Robert W. Baird Downgraded its Outperform to Neutral on April 15, 2025, while the target price for the stock was maintained at $224.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Oct 29 ’25 when SUSSMAN ELLIOT J MD MBA sold 965 shares for $225.70 per share. The transaction valued at 217,799 led to the insider holds 6,113 shares of the business.
ELLIOT SUSSMAN bought 965 shares of UHS for $217,799 on Oct 29 ’25. On May 14 ’25, another insider, Singer Maria Ruderman, who serves as the Director of the company, sold 1,097 shares for $191.48 each. As a result, the insider received 210,053 and left with 7,884 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UHS now has a Market Capitalization of 13917145088 and an Enterprise Value of 18897596416. As of this moment, Universal’s Price-to-Earnings (P/E) ratio for their current fiscal year is 10.39, and their Forward P/E ratio for the next fiscal year is 9.47. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.67. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.82 while its Price-to-Book (P/B) ratio in mrq is 1.98. Its current Enterprise Value per Revenue stands at 1.112 whereas that against EBITDA is 7.397.
Stock Price History:
The Beta on a monthly basis for UHS is 1.33, which has changed by 0.06542921 over the last 52 weeks, in comparison to a change of 0.19088471 over the same period for the S&P500. Over the past 52 weeks, UHS has reached a high of $227.22, while it has fallen to a 52-week low of $152.33. The 50-Day Moving Average of the stock is 10.85%, while the 200-Day Moving Average is calculated to be 19.02%.
Shares Statistics:
It appears that UHS traded 721.28K shares on average per day over the past three months and 700760 shares per day over the past ten days. A total of 63.64M shares are outstanding, with a floating share count of 53.86M. Insiders hold about 15.37% of the company’s shares, while institutions hold 84.22% stake in the company. Shares short for UHS as of 1760486400 were 1878407 with a Short Ratio of 2.60, compared to 1757894400 on 2458813. Therefore, it implies a Short% of Shares Outstanding of 1878407 and a Short% of Float of 4.75.
Dividends & Splits
With its trailing 12-month dividend rate of 0.8, UHS has a forward annual dividend rate of 0.80. Against a Trailing Annual Dividend Yield of 0.0035508212. The stock’s 5-year Average Dividend Yield is 0.48. The current Payout Ratio is 4.76% for UHS, which recently paid a dividend on 2025-09-02 with an ex-dividend date of 2025-09-02. Stock splits for the company last occurred on 2009-12-16 when the company split stock in a 2:1 ratio.
Earnings Estimates
As of right now, 12.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $5.26, with high estimates of $5.96 and low estimates of $4.88.
Analysts are recommending an EPS of between $21.92 and $20.12 for the fiscal current year, implying an average EPS of $21.4. EPS for the following year is $23.01, with 13.0 analysts recommending between $24.83 and $20.05.
Revenue Estimates
In. The current quarter, 13 analysts expect revenue to total $4.5B. It ranges from a high estimate of $4.57B to a low estimate of $4.45B. As of. The current estimate, Universal Health Services, Inc’s year-ago sales were $4.11BFor the next quarter, 13 analysts are estimating revenue of $4.33B. There is a high estimate of $4.43B for the next quarter, whereas the lowest estimate is $4.22B.
A total of 15 analysts have provided revenue estimates for UHS’s current fiscal year. The highest revenue estimate was $17.45B, while the lowest revenue estimate was $17.17B, resulting in an average revenue estimate of $17.35B. In the same quarter a year ago, actual revenue was $15.83BBased on 16 analysts’ estimates, the company’s revenue will be $18.17B in the next fiscal year. The high estimate is $18.6B and the low estimate is $17.7B.
